LUIS A GARZA, MD-PHD
Dermatology at Caroline St, Baltimore, MD

License number
Maryland D69136
Category
Osteopathic Medicine
Type
Dermatology
License number
Maryland MD426253
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
601 N Caroline St, Baltimore, MD 21287
Phone
(410) 955-5933

Professional information

Luis Garza Photo 1

Minimally Invasive Skin Biopsy Device For Removal Of Skin Conditions In The Epidermis

US Patent:
2014007, Mar 13, 2014
Filed:
May 9, 2011
Appl. No.:
14/116456
Inventors:
Danielle Nicole Dorfman - Miami FL, US
Yifu Ding - Souderton PA, US
Chirag Shah - San Jose CA, US
Andrew S. Harwell - Baltimore MD, US
Marie Kelly - Baltimore MD, US
Anna Chien - Columbia MD, US
Luis Garza - Baltimore MD, US
Janice Taube - Baltimore MD, US
Anish Bhatnagar - Sandy UT, US
Desai Pujan - Houston TX, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61B 10/02
US Classification:
600564
Abstract:
An embodiment in accordance with the present invention provides a device for performing a skin biopsy that includes a generally curved blade to cut the skin at a predetermined depth disposed within or an integral part of a blade holder assembly. The blade holder assembly has an outer surface and the generally curved blade is coupled to the outer surface of the blade holder assembly. The device also includes a housing having an outer wall and said outer wall defining an interior space within the housing, such that the blade holder assembly and generally curved blade are disposed substantially within the inner space of the housing. The device also includes a handle coupled to the blade holder assembly and configured to rotate the blade holder assembly and in turn the generally curved blade within the inner space of the housing to perform the skin biopsy or removal of skin conditions.


Luis Andres Garza Photo 2

Luis Andres Garza, Baltimore MD

Specialties:
Dermatology, Allergy & Immunology, Anatomic Pathology
Work:
Johns Hopkins Outpatient Center
601 N Caroline St, Baltimore, MD 21287 The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287 Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore, MD 21224 Hospital of the University of PA
3400 Civic Center Blvd, Philadelphia, PA 19104
Education:
University of Pennsylvania(2001)


Luis A Garza Photo 3

Luis A Garza, Philadelphia PA

Specialties:
Dermatologist
Address:
3400 Spruce St, Philadelphia, PA 19104
601 N Caroline St, Baltimore, MD 21287


Luis Garza Photo 4

Methods And Compositions For Inhibiting Or Reducing Hair Loss, Acne, Rosacea, Prostate Cancer, And Bph

US Patent:
2011002, Jan 27, 2011
Filed:
Jun 15, 2007
Appl. No.:
12/303998
Inventors:
George Cotsarelis - Berwyn PA, US
Luis Garza - Baltimore MD, US
International Classification:
A61K 31/713, A61K 31/557, A61K 31/7088, A61K 8/36, A61P 17/00, A61P 35/00, A61Q 7/00
US Classification:
514 44 A, 514573, 514 44 R
Abstract:
This invention provides methods of treating androgenetic alopecia (AGA), acne, rosacea, prostate cancer, and benign prostatic hypertrophy (BPH), comprising the step of contacting a subject with a compound or composition capable of decreasing prostaglandin D2 (PGD2) level or activity, a downstream signaling or receptor pathway thereof, or prostaglandin D2 synthase level or activity; methods of stimulating hair growth, comprising the step of contacting a subject with a compound or composition capable of increasing or decreasing the activity or level of a target gene of the present invention, or with a protein product of the target gene or an analogue or mimetic thereof; and methods of testing for AGA and evaluating therapeutic methods thereof, comprising measuring PGD2 levels.


Luis Garza Photo 5

Hyperspectral Imaging For Detection Of Skin Related Conditions

US Patent:
2013011, May 9, 2013
Filed:
Sep 25, 2012
Appl. No.:
13/626301
Inventors:
Philippe M. Burlina - North Bethesda MD, US
Amit Banerjee - Burtonsville MD, US
Saurabh Vyas - Odenton MD, US
Luis Garza - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
G06K 9/78
US Classification:
382128
Abstract:
A method of detecting a skin condition may include employing a multiband hyperspectral sensor to obtain multi-spectral data, employing the multi-spectral data to map constitutive skin parameters to corresponding spectral signatures via a forward model that enables generation of a set of samples including a plurality of parameters mapped to a plurality of spectral signatures, utilizing the set of samples to employ machine learning to generate an inverse model to enable mapping of a spectral signature of skin of a patient to corresponding skin parameters, estimatingconstitutive skin parameters of the skin of the patient based on the inverse model, and determining a distribution of the constitutive parameters for one or more skin locations.


Luis Garza Photo 6

Topical Compositions And Methods Of Detection And Treatment

US Patent:
2013002, Jan 24, 2013
Filed:
Sep 19, 2012
Appl. No.:
13/622666
Inventors:
The Johns Hopkins University - Baltimore MD, US
Julia B. Patrone - Ellicott City MD, US
Jason J. Benkoski - Ellicott City MD, US
Jennifer L. Breidenich - Atlanta MD, US
Lisa A. Kelly - Ellicott City MD, US
Le Huong - Olney MD, US
James C. Crookston - Falls Church VA, US
Marcia W. Patchan - Columbia MD, US
Luis Garza - Baltimore MD, US
Xiomara Calderon-Colon - Laurel MD, US
Joshua T. Wolfe - Bethesda MD, US
Mellisa L. Theodore - Nottingham MD, US
Amanda Nelson - Hummelstown PA, US
Sewon Kang - Phoenix MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 9/107, A61K 31/436, A61P 17/14, A61P 17/00, A61K 38/13, A61K 31/506, B82Y 5/00
US Classification:
424498, 424490, 514 207, 514291, 514275, 977773, 977906
Abstract:
A topical composition includes a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein. The hydrophobic particles are derived from the same or different hydrophobic material and each hydrophobic particle has a melting point below the melting point of the respective hydrophobic material. The hydrophobic particles comprise a mean particle size of less than about 10 nm, and the nanoemulsion further includes one or more pharmaceutically active agents.